MX2014005153A - Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. - Google Patents
Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain.Info
- Publication number
- MX2014005153A MX2014005153A MX2014005153A MX2014005153A MX2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A MX 2014005153 A MX2014005153 A MX 2014005153A
- Authority
- MX
- Mexico
- Prior art keywords
- pain
- pharmaceutical composition
- tramadol hydrochloride
- ketorolac tromethamine
- production method
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
Abstract
The invention relates to an oral pharmaceutical composition combining ketorolac tromethamine/tramadol hydrochloride, for the treatment of allopathic pain (moderate to severe), used as an analgesic, anti-inflammatory, fever reducer or antipyretic, for oral administration and, in particular, in the form of a sublingual tablet.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2014005153A MX2014005153A (en) | 2014-04-29 | 2014-04-29 | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. |
PCT/IB2015/053098 WO2015166419A2 (en) | 2014-04-29 | 2015-04-29 | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain |
CL2016002656A CL2016002656A1 (en) | 2014-04-29 | 2016-10-19 | Process for obtaining and pharmaceutical composition of ketorolac tromethamine and sublingual tramadol hydrochloride used for pain. |
SV2016005309A SV2016005309A (en) | 2014-04-29 | 2016-10-28 | PROCESS OF OBTAINING AND PHARMACEUTICAL COMPOSITION FOR KETOROLACO TROMETAMINE AND SUBLINGUAL TRAMADOL CHLORHYDRATE USED FOR PAIN |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2014005153A MX2014005153A (en) | 2014-04-29 | 2014-04-29 | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014005153A true MX2014005153A (en) | 2015-10-28 |
Family
ID=54359445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014005153A MX2014005153A (en) | 2014-04-29 | 2014-04-29 | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. |
Country Status (4)
Country | Link |
---|---|
CL (1) | CL2016002656A1 (en) |
MX (1) | MX2014005153A (en) |
SV (1) | SV2016005309A (en) |
WO (1) | WO2015166419A2 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2607661C1 (en) * | 2015-11-30 | 2017-01-10 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) | Rectal suppositories with analgesic action |
WO2019143234A1 (en) | 2018-01-22 | 2019-07-25 | AMÉZCUA AMÉZCUA, Federico | Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019122982A1 (en) | 2017-12-21 | 2019-06-27 | Grünenthal GmbH | Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2007003948A (en) * | 2007-04-02 | 2009-02-25 | World Trade Imp Export Wtie Ag | Pharmaceutical composition in the form of a sublingual tablet consisting of a non-steroidal anti-inflammatory agent and an opiate analgesic for pain management. |
-
2014
- 2014-04-29 MX MX2014005153A patent/MX2014005153A/en unknown
-
2015
- 2015-04-29 WO PCT/IB2015/053098 patent/WO2015166419A2/en active Application Filing
-
2016
- 2016-10-19 CL CL2016002656A patent/CL2016002656A1/en unknown
- 2016-10-28 SV SV2016005309A patent/SV2016005309A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2607661C1 (en) * | 2015-11-30 | 2017-01-10 | Федеральное государственное бюджетное учреждение науки Институт органического синтеза им. И.Я. Постовского Уральского отделения Российской академии наук (ИОС УрО РАН) | Rectal suppositories with analgesic action |
WO2019143234A1 (en) | 2018-01-22 | 2019-07-25 | AMÉZCUA AMÉZCUA, Federico | Synergistic pharmaceutical combination of the active enantiomer s-ketorolac tromethamine and tramadol chlorhydrate |
Also Published As
Publication number | Publication date |
---|---|
CL2016002656A1 (en) | 2017-02-17 |
SV2016005309A (en) | 2017-05-15 |
WO2015166419A3 (en) | 2016-01-07 |
WO2015166419A2 (en) | 2015-11-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12020500066A1 (en) | Carboxamides as modulators of sodium channels | |
PH12018502251A1 (en) | Formulations of an lsd1 inhibitor | |
MY196173A (en) | Cot Modulators And Methods Of Use Thereof | |
PH12016501830A1 (en) | Inhibitors of c5a for the treatment of viral pneumonia | |
MX2016006623A (en) | Autotaxin inhibitor compounds. | |
IL285899A (en) | Pharmaceutical dosage form for application to mucous membranes and methods for producing same | |
MX2022001796A (en) | Methods and compositions to inhibit symptoms associated with veisalgia. | |
MX2017003216A (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients. | |
MX2017015137A (en) | Once daily oral pharmaceutical composition of isotretinoin. | |
PH12016502530A1 (en) | Pharmaceutical compositions comprising dgla and use of same | |
PH12015501377A1 (en) | Solid unit with high fexofenadine content and process for the preparation thereof | |
MX2014005153A (en) | Production method and sublingual pharmaceutical composition of ketorolac tromethamine and tramadol hydrochloride used for pain. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2017015322A (en) | Oral pharmaceutical composition of isotretinoin. | |
WO2015166418A3 (en) | Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient | |
IN2013MU03428A (en) | ||
MX2020000213A (en) | Novel composition of enzalutamide oral dosage form and method of manufacturing thereof. | |
EP3468558A4 (en) | Pharmaceutical compositions comprising an opioid analgesic and an antiemetic to treat pain | |
TW201611830A (en) | Pharmaceutical formulation for reducing bladder spasms and method of use thereof | |
MX2017001192A (en) | Pharmaceutical composition of loratadine, phenylephrine, paracetamol and amantadine for oral administration, for the treatment of allopathies related to a common cold. | |
MX357376B (en) | Pharmaceutical composition for use against inflammation and pain. | |
WO2019132729A3 (en) | Indomethacin menthyl ester-based pharmaceutical compositions and use thereof | |
MX2016010919A (en) | 4-benzylsulfonyl-2-butenenitrile. | |
MX2014013240A (en) | Pharmaceutical tablet composition for the treatment of erectile dysfunction based on a drug inhibiting the pde5 enzyme (phosphodiesterase type 5). | |
MX345917B (en) | Analgesic compositions comprising quercetin and ketorolac. |